Chemoinformaics analysis of CHRYSOPHANIC-ACID-DIMER
| Molecular Weight | 474.374 | nRot | 9 |
| Heavy Atom Molecular Weight | 456.23 | nRig | 18 |
| Exact Molecular Weight | 474.08 | nRing | 2 |
| Solubility: LogS | -3.503 | nHRing | 0 |
| Solubility: LogP | 1.672 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 10 | APOL | 58.3663 |
| nHD | 6 | BPOL | 25.0017 |
| QED | 0.172 |
| Synth | 3.514 |
| Natural Product Likeliness | 0.705 |
| NR-PPAR-gamma | 0.851 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.009 |
| HIA | 0.59 |
| CACO-2 | -6.45 |
| MDCK | 0.0000107 |
| BBB | 0.074 |
| PPB | 0.988276 |
| VDSS | 0.296 |
| FU | 0.0165457 |
| CYP1A2-inh | 0.057 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.07 |
| CYP2c19-sub | 0.029 |
| CYP2c9-inh | 0.402 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.122 |
| CYP3a4-inh | 0.066 |
| CYP3a4-sub | 0.007 |
| CL | 4.971 |
| T12 | 0.974 |
| hERG | 0.01 |
| Ames | 0.004 |
| ROA | 0.099 |
| SkinSen | 0.906 |
| Carcinogencity | 0.127 |
| EI | 0.351 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.106 |
| Antiviral | Yes |
| Prediction | 0.741912 |